March 21, 2019 Digital health:Bayer is taking collaboration with health care start-ups to the next levelRead more
March 19, 2019 Bayer statement on jury’s decision in phase one of California glyphosate trialRead more
March 14, 2019 Not intended for U.S. and UK Media – Neglected Tropical DiseasesPhase III clinical trial with Bayer’s nifurtimox demonstrates safety and efficacy of new formulation to treat children with Chagas diseaseRead more
SPECIALIZED PRESS March 8, 2019 Not intended for U.S. and UK MediaBayer submits European marketing authorization application for darolutamideRead more
March 7, 2019 2018 Aspirin Social Innovation Awards from Bayer Cares FoundationImpact pioneers honored for groundbreaking ideas in the fields of healthcare and nutritionRead more
SPECIALIZED PRESS March 5, 2019 Not intended for U.S. and UK MediaBayer submits darolutamide for marketing authorization in JapanRead more
February 28, 2019 Conviso™ Smart: Successful licensing agreement between Bayer AG, KWS SAAT SE and MariboHilleshögRead more
SPECIALIZED PRESS February 28, 2019 Not intended for U.S. and UK MediaBayer presents next generation CT injector, MEDRAD™ Centargo, at European Congress of Radiology 2019Read more
February 28, 2019 Award from the Bayer Science & Education Foundation:Bayer Thrombosis Research Award 2019 goes to Dr. Changjun YinRead more
.jpg)
